Company profile
Pfizer
Diversified pharma
Share price · PFE
$27.25+1.92 (+7.58%) 3M
Loading chart…
Prices are end-of-day (EOD), delayed by 24 hours · Unadjusted for historical splits · Data via Databento
Assets
(66 total)
66Total Assets
34Approved
15Phase 3 / Filed
17Phase 1–2 / Early
18Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
abrocitinib(Cibinqo) | Approved | JAK1Small molecule | Atopic Dermatitis |
| Approved | MEK1/2Small molecule | Non-Small Cell Lung Cancer | |
crisaborole(Eucrisa) | Approved | PDE4Small molecule | Atopic Dermatitis |
| Approved | ALK, ROS1, MET/HGFR, and RONSmall molecule | Non-Small Cell Lung Cancer | |
| Approved | EGFR/HER1, HER2, HER4Small molecule | Non-Small Cell Lung Cancer | |
| Approved | BCMA x CD3Monoclonal antibody | Multiple Myeloma | |
| Approved | BRAF V600ESmall molecule | Non-Small Cell Lung Cancer | |
Ertugliflozin(Steglatro) | Approved | SGLT2Small molecule | Type 2 Diabetes |
| Approved | T-type calcium channelSmall molecule | Epilepsy | |
etrasimod(Velsipity) | Approved | S1P receptorSmall molecule | Inflammatory Bowel DiseaseAtopic Dermatitis Ulcerative Colitis |
| Approved | AromataseSmall molecule | HR+/HER2- Breast Cancer HR+/HER2- Metastatic Breast Cancer | |
| Approved | Voltage-gated sodium channelSmall molecule | Epilepsy | |
| Approved | α2δ subunit of voltage-gated calcium channelsSmall molecule | Epilepsy | |
| Approved | PI3K (class I isoforms) and mTORC1/mTORC2Small molecule | HR+/HER2- Breast Cancer HR+/HER2- Metastatic Breast Cancer | |
| Approved | CD33Antibody–drug conjugate | Acute Myeloid Leukemia |
Upcoming events
Research
Sign in to access ResearchUnlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Sign in to access ResearchUnlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.
Insider transactions
Research
Sign in to access ResearchUnlock insider transactions
Research includes SEC Form 4 insider transactions — filed buys, sells, awards and exercises linked to the underlying filings.
Institutional holders
Research
Sign in to access ResearchUnlock institutional holders
Research includes quarterly SEC 13F institutional ownership — top holders, aggregate positions and quarter-over-quarter context.